Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Lung Diseases(Electronic Edition) ›› 2026, Vol. 19 ›› Issue (04): 586-592. doi: 10.3877/cma.j.issn.1674-6902.2026.04.009

• Original Article • Previous Articles    

Retrospective study of PIV, PLR combined with D-Dimer and cardiac troponin I in risk stratification of 123 cases with acute pulmonary embolism

Jinqiang Wang1, Nini Wang2, Rongrong Chen2, Chengshi Zhang2, Qing Zhang2, Qiliang Feng2, Ming Liu2, Lianyun Cheng2, Yunfeng Zhao2, Han Lei2,(), Eryun Qin2,()   

  1. 1Department of Respiratory Medicine, Tongxiang Hospital of Traditional Chinese Medicine, Tongxiang 314500, China
    2Department of Respiratory Medicine, Punan Hospital, Pudong New Area, Shanghai 200125, China
  • Received:2026-03-16 Online:2026-08-25 Published:2026-09-07
  • Contact: Han Lei, Eryun Qin

Abstract:

Objective

To investigate the correlation of pan-immune-inflammation value (PIV), platelet-to-lymphocyte ratio (PLR), D-dimer (D-D) and cardiac troponin I (cTnI), as well as their combined index, with the risk stratification of acute pulmonary embolism (APE).

Methods

A total of 123 APE patients admitted to Tongxiang Hospital of Traditional Chinese Medicine (Zhejiang Province) and Punan Hospital of Pudong New Area (Shanghai) from January 2021 to October 2025 were enrolled. According to pulmonary embolism severity index (PESI) scores, patients were divided into low-risk group (39 cases) and intermediate-high-risk group (84 cases). The influencing factors of APE risk stratification were analyzed, and the predictive value of single and combined indicators for APE severity was evaluated.

Results

The neutrophil count in the intermediate-high risk group was 5.31(3.95, 7.95)×109/L, monocyte count 0.64(0.47, 0.81)×109/L, PIV 565.55 (373.41, 1030.36), D-dimer 7.62(4.08, 15.18)mg/L, cTnI 20.52(8.29, 36.91)ng/ml, SII 992.30(696.69, 1 828.96), NLR 4.46(3.10, 9.44), and PLR 181.56(131.90, 281.31), which were higher than those in the low-risk group [4.46 (3.12, 5.91)×109/L, 0.44 (0.35, 0.51)×109/L, 171.77(127.51, 333.45), 4.31(1.54, 6.89)mg/L, 5.35(2.88, 11.94)ng/ml, 494.21 (295.97, 840.78), 2.67(1.66, 4.39), and 109.03(91.24, 144.61), respectively]; while the lymphocyte count in the intermediate-high risk group was 1.14(0.76, 1.38), lower than that in the low-risk group [1.84 (1.27, 2.12)], and the differences between groups were statistically significant (P<0.05). Multivariate binary Logistic regression analysis confirmed that high levels of PIV, PLR, D-D and cTnI were independent risk factors for intermediate-high-risk APE. Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) of PIV, PLR, D-D and cTnI for predicting intermediate-high-risk APE was 0.827 (95%CI: 0.743~0.911), 0.769(95%CI: 0.681~0.857), 0.694 (95%CI: 0.598~0.790) and 0.735 (95%CI: 0.634~0.835), respectively, while the combined index had an AUC of 0.884 (95%CI: 0.817~0.951). At the optimal cut-off value of 0.560, the sensitivity, specificity and Youden index were 89.29%, 74.26% and 0.636, respectively.

Conclusion

PIV, PLR, D-D and cTnI are influencing factors for the occurrence of intermediate-high risk pulmonary embolism. Elevated levels of PIV, PLR combined with D-D and cTnI are closely correlated with the risk stratification of APE. Combined detection can effectively improve the early identification ability of intermediate-high risk APE and facilitate clinical evaluation.

Key words: Acute pulmonary embolism, Disease severity, D-dimer, Troponin I, Pan-immune-inflammation Value, Systemic immune-inflammation index, Platelet-to-lymphocyte ratio, Neutrophil-to-lymphocyte ratio

京ICP 备07035254号-28
Copyright © Chinese Journal of Lung Diseases(Electronic Edition), All Rights Reserved.
Tel: 023-65425691 E-mail: xqcjld@163.com
Powered by Beijing Magtech Co. Ltd